---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-047965"
form_type: "8-K"
ticker: "CPHI"
cik: "0001106644"
company_name: "CHINA PHARMA HOLDINGS, INC."
filed_at: "2024-05-30T23:59:59+00:00"
generated_at: "2026-06-01T07:19:41.926815+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# China Pharma extends convertible note maturity to Aug. 2025; minimum monthly payment cut 75%

## Summary
- Maturity date of $557,735 convertible note (Streeterville Capital) extended to August 19, 2025.
- Extension fee equal to 2% of outstanding balance added to principal; balance post-fee is $557,735.
- Minimum monthly redemption amount reduced from $150,000 to $37,182.33 per month.
- Original note principal was $5,250,000 issued November 2021; prior amendment in April 2023.

## SEC filing metadata
- accession: 0001213900-24-047965
- form_type: 8-K
- ticker: CPHI
- cik: 0001106644
- company_name: CHINA PHARMA HOLDINGS, INC.
- filed_at: 2024-05-30T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1106644/000121390024047965/0001213900-24-047965-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1106644/000121390024047965/ea0207083-8k_china.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-047965
- JSON: https://secwatch.observer/filing/0001213900-24-047965.json
- Plain text: https://secwatch.observer/filing/0001213900-24-047965.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.